Advanced Micro Devices (AMD) plans to make an equity investment in quantum-computing company PsiQuantum as the two companies expand a partnership aimed at building the computing infrastructure required for utility-scale, fault-tolerant quantum machines. The agreement, announced on Thursday, November 12, brings AMD’s processors, graphics accelerators and software together with PsiQuantum’s photonic quantum technology.
The companies say they will co-design systems that combine quantum computing with conventional high-performance computing and artificial intelligence. The size of AMD’s planned investment has not been disclosed. The partnership is also intended to develop applications in areas such as pharmaceutical research, materials science and other fields where large-scale simulations could be valuable.
AMD Brings CPUs, GPUs And Software To The Partnership
Under the expanded agreement, AMD will provide EPYC central processing units, Instinct graphics processing units, adaptive computing technology and its ROCm software stack. PsiQuantum will contribute its silicon-photonics platform, which uses light to transmit information and is designed to support large-scale photonic quantum systems.
The companies say the work will build on an existing relationship involving AMD Versal field-programmable gate arrays. The expanded collaboration is intended to address the control, processing and error-correction requirements of fault-tolerant quantum computers, which must manage fragile quantum information while operating at a much larger scale than current experimental systems.
AMD did not disclose the value of its planned equity investment. The announcement also did not provide a commercial delivery date for a completed utility-scale quantum computer. The agreement is therefore best understood as a strategic technology and infrastructure partnership, rather than evidence that a commercially useful machine is ready for deployment.
Drug Discovery Is An Early Application Area
The companies identified pharmaceutical research as an initial area of interest. PsiQuantum said its computational chemistry workflows are already running on AMD hardware and that early work has produced promising results in simulations of covalent inhibitors, a class of molecules relevant to oncology drug discovery.
The companies have not presented the results as a new cancer treatment or a clinical breakthrough. The work concerns computational modelling that may help researchers study molecular behaviour and evaluate possible drug candidates. Further experimental validation, development and testing would be required before any discovery could translate into a medicine.
Hybrid computing is central to the strategy. Conventional processors and GPUs remain essential for data handling, simulation and control, while quantum processors could eventually address particular classes of problems that are difficult for classical machines. The partnership is designed to make those different systems work together rather than treating quantum computers as replacements for existing infrastructure.
U.S. Government Funding Adds Strategic Weight
The partnership arrives as the United States increases support for domestic quantum technology. The National Institute of Standards and Technology said in September that the Commerce Department had finalised an award of up to $100 million for PsiQuantum under the CHIPS and Science Act. The funding is intended to address photonic quantum-computing challenges involving electro-optic materials, single-photon detectors and low-loss photonic packaging.
PsiQuantum is also developing sites in the United States and Australia. The company has identified Chicago’s Illinois Quantum and Microelectronics Park as a potential location for an expanded collaboration with AMD. It said the companies would share more about their work at the SC26 conference in Chicago from November 15 to 20.
The government funding and private-sector partnership reflect a wider race to build quantum systems that can operate reliably at scale. But the technology still faces substantial engineering challenges, including error correction, manufacturing consistency, photonic losses and the integration of quantum processors with conventional computing infrastructure.
HeadlinesXtra Analysis
AMD’s investment plan is strategically important because quantum computing will need a large classical-computing ecosystem around it. Even a powerful quantum processor depends on conventional chips, software, networking and control systems. AMD’s involvement could position the company to supply more of that infrastructure if PsiQuantum’s photonic approach advances towards commercial scale.
The partnership should not be confused with proof that fault-tolerant quantum computers are close to widespread commercial use. The companies have announced a development programme and an undisclosed investment, not a finished product or a confirmed date for large-scale deployment. The technical milestones will matter more than the announcement itself.
The early drug-discovery work is worth watching, but its claims need independent scientific validation. Simulations of covalent inhibitors may help researchers explore complex chemistry, yet the route from a promising computational result to a safe and effective medicine is long. For now, the clearest significance is the growing convergence of AI, high-performance computing and quantum research — and the effort by major chip suppliers to secure a role in that future.
Sources And Further Reading
- AMD Newsroom: PsiQuantum And AMD Collaborate To Build The Computing Foundation For Utility-Scale Quantum Computing — official company announcement, November 12, 2026.
- PsiQuantum: Company News And Technology Overview — official description of its silicon-photonics platform and utility-scale quantum-computing plans.
- Reuters: AMD To Invest In PsiQuantum To Advance Quantum Computing Infrastructure — independent reporting on the partnership and investment plan.
- Business Wire Via Nasdaq: PsiQuantum And AMD Collaboration Announcement — detailed description of the technology and applications.
- National Institute Of Standards And Technology: Commerce Department Finalises CHIPS R&D Award With PsiQuantum — official details of the federal award.